Compugen (CGEN) Enterprise Value Growth (5y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.20% |
| Jun 30, 2025 | 13.18% |
| Dec 31, 2024 | -51.92% |
| Jun 30, 2024 | -11.60% |
| Dec 31, 2023 | -15.05% |
| Jun 30, 2023 | -8.85% |
| Dec 31, 2022 | 16.05% |
| Jun 30, 2022 | 13.43% |
| Dec 31, 2021 | -61.35% |
| Jun 30, 2021 | 6.24% |
| Dec 31, 2020 | -59.86% |
| Jun 30, 2020 | 12.92% |
| Dec 31, 2019 | 17.78% |
| Jun 30, 2019 | 24.99% |
| Dec 31, 2018 | 24.54% |
| Jun 30, 2018 | 2.59% |
| Dec 31, 2017 | -6.25% |
| Jun 30, 2017 | -15.13% |
| Dec 31, 2016 | 13.71% |
| Jun 30, 2016 | -9.72% |
| Dec 31, 2015 | 11.49% |
| Jun 30, 2015 | -11.38% |
| Mar 31, 2015 | -29.00% |
| Dec 31, 2014 | -11.35% |
| Jun 30, 2014 | -44.11% |